AstraZeneca is showing no signs of restarting a 200 million pound sterling ($273 million) investment in its U.K. hometown, despite keeping its options open. AstraZeneca paused the investment in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results